Metropolitan Life Insurance CO Eye Point Pharmaceuticals, Inc. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$19.93 - $29.71 $10,523 - $15,686	528 Added 36.51%	1,974 $40,000
Q2 2023 Aug 10, 2023	BUY	$3.03 - $9.0 $4,381 - $13,014	1,446 New	1,446 $12,000
Q3 2022 Jun 14, 2023	BUY	$6.96 - $11.12 $12,200 - $19,493	1,753 New	1,753 $13.9 Million
Q2 2022 Jun 20, 2023	BUY	$7.25 - $12.71 $12,709 - $22,280	1,753 New	1,753 $13,000
Q1 2022 Jun 20, 2023	BUY	$8.67 - $14.11 $15,198 - $24,734	1,753 New	1,753 $21,000
Q1 2022 Mar 30, 2023	SELL	$8.67 - $14.11 $37,879 - $61,646	-4,369 Reduced 71.37%	1,753 $21,000
Q1 2022 May 12, 2022	SELL	$8.67 - $14.11 $37,879 - $61,646	-4,369 Reduced 71.37%	1,753 $21,000
Q4 2021 Jun 21, 2023	BUY	$10.18 - $18.4 $62,321 - $112,644	6,122 New	6,122 $74,000
Q4 2021 Mar 30, 2023	BUY	$10.18 - $18.4 $62,321 - $112,644	6,122 New	6,122 $74,000
Q4 2021 Feb 15, 2022	BUY	$10.18 - $18.4 $62,321 - $112,644	6,122 New	6,122 $75,000

150

58M

177K

263K

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $357M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.